This week, there are 18 drugs in the patent and exclusivity list. They are: - SUNOVION PHARMACEUTICALS INC's LATUDA, containing active ingredient LURASIDONE HYDROCHLORIDE - VERTEX PHARMACEUTICALS INC's TRIKAFTA (COPACKAGED), containing active ingredient ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR - VERTEX PHARMACEUTICALS INC's KALYDECO, containing active ingredient IVACAFTOR - VERTEX PHARMACEUTICALS INC's SYMDEKO (COPACKAGED), containing active ingredient IVACAFTOR; IVACAFTOR, TEZACAFTOR - TAKEDA PHARMACEUTICALS USA INC's KAZANO, containing active ingredient ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE - VERTEX PHARMACEUTICALS INC's ALYFTREK, containing active ingredient DEUTIVACAFTOR; TEZACAFTOR; VANZACAFTOR CALCIUM Read More

Tirzepatide, a dual GIP/GLP-1 receptor agonist, represents a breakthrough in obesity and type 2 diabetes treatment. This article explores its synergistic mechanism, superior clinical outcomes, and global market potential. It also highlights how Unibest supports global pharma companies with API sourcing, licensing, and regulatory services in the incretin drug space. Read More

This week, there are 9 drugs in the patent and exclusivity list. They are: - BRISTOL MYERS SQUIBB CO's POMALYST, containing active ingredient POMALIDOMIDE - VIATRIS SPECIALTY LLC's TOBI PODHALER, containing active ingredient TOBRAMYCIN - RHYTHM PHARMACEUTICALS INC's IMCIVREE, containing active ingredient SETMELANOTIDE ACETATE - PF PRISM CV's BOSULIF, containing active ingredient BOSUTINIB MONOHYDRATE - JANSSEN PHARMACEUTICALS INC's XARELTO, containing active ingredient RIVAROXABAN - BPI LABS LLC's ABLYSINOL, containing active ingredient ALCOHOL - HORIZON THERAPEUTICS USA INC's PROCYSBI, containing active ingredient CYSTEAMINE BITARTRATE - NOVARTIS PHARMACEUTICALS CORP's TAFINLAR, containing active ingredient DABRAFENIB MESYLATE - NOVARTIS PHARMACEUTICALS CORP's MEKINIST, containing active ingredient TRAMETINIB DIMETHYL SULFOXIDE Read More

This week, there are 6 drugs in the patent and exclusivity list. They are: - NOVARTIS PHARMACEUTICALS CORP's TAFINLAR, containing active ingredient DABRAFENIB MESYLATE - NOVARTIS PHARMACEUTICALS CORP's MEKINIST, containing active ingredient TRAMETINIB DIMETHYL SULFOXIDE - COLLEGIUM PHARMACEUTICAL INC's XTAMPZA ER, containing active ingredient OXYCODONE - ELI LILLY AND CO's OLUMIANT, containing active ingredient BARICITINIB - MEDICINES DEVELOPMENT FOR GLOBAL HEALTH's MOXIDECTIN, containing active ingredient MOXIDECTIN - JAZZ PHARMACEUTICALS IRELAND LTD's ZEPZELCA, containing active ingredient LURBINECTEDIN Read More

This week, there are 5 drugs in the patent and exclusivity list. They are: - PARATEK PHARMACEUTICALS INC's NUZYRA, containing active ingredient OMADACYCLINE TOSYLATE - SANDOZ INC's CIPRODEX, containing active ingredient CIPROFLOXACIN; DEXAMETHASONE - BRAEBURN INC's BRIXADI, containing active ingredient BUPRENORPHINE - INSMED INC's ARIKAYCE KIT, containing active ingredient AMIKACIN SULFATE - ABBVIE INC's VENCLEXTA, containing active ingredient VENETOCLAX Read More

Query Drug：TirzepatideQuery Time：2025-05-29 16:35:52*** Disclaimer *** The information provided here is sourced from resources such as Drugs.com, the Orange Book, etc., and is auto-generated by the Unibest Digital Center. The content is intended exclusively for pharmaceutical professionals. Read More

EpimAb Biotherapeutics has successfully implemented the NewCo model through two significant deals in 2024-2025: licensing EMB-06 to Vignette Bio and a T-cell engaging molecule to Juri Biosciences. Read More

This article explores the intersection of virology and oncology, examining how scientists harness viruses' natural abilities to combat cancer. Unibest is pleased to present an oncolytic virus asset, currently in Phase II trials, that is open for global licensing and co-development opportunities. Read More

Obesity is a global health crisis affecting over 650 million people worldwide. But there's hope on the horizon. Recent breakthroughs in understanding how our gut and pancreatic hormones regulate appetite and blood sugar have led to the development of exciting new medicines to treat obesity and relat Read More